Form 4: Vor Biopharma CEO Robert Ang Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Robert Ang, CEO of Vor Biopharma Inc., disposed of 2,361 shares of common stock on May 6, 2025, to satisfy tax withholding obligations related to the settlement of restricted stock units.
Summary
- On May 6, 2025, Robert Ang, the President and CEO of Vor Biopharma Inc., disposed of 2,361 shares of common stock.
- The transaction was executed to cover tax withholding obligations associated with the settlement of restricted stock units.
- The shares were disposed of at a price of $0.56 per share.
- Following the transaction, Ang directly owns 911,318 shares of Vor Biopharma Inc.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock transactions for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine sale of shares to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 05/06/2025 | Date of transaction: Robert Ang disposed of shares to cover tax obligations. |
| 05/07/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, Robert Ang, Vor Biopharma, Stock Disposal, Tax Withholding, Restricted Stock Units, VOR
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.